Skip to main content

Day: February 24, 2025

Globe Telecom, Nokia collaborate on network APIs to provide banks with enhanced security #MWC25

Press releaseGlobe Telecom, Nokia collaborate on network APIs to provide banks with enhanced security #MWC25Globe tests Nokia’s Network Exposure Platform (NEP) to enhance security in financial services.24 February 2025Espoo, Finland – Globe Telecom, one of the largest telecommunications operators in the Philippines with over 60 million subscribers, today announced that it is collaborating with Nokia to provide banks and other enterprises with enhanced security through the utilization of network Application Programming Interfaces (APIs). Globe Telecom, which already uses a host of other Nokia solutions including 5G RAN, is testing Nokia’s Network Exposure Platform in expanding and simplifying the number of APIs available to the operator and its enterprise partners to enable the creation of security-focused applications. APIs provide...

Continue reading

FRO – Invitation to Q4 2024 Results Conference Call and Webcast

Frontline plc.’s preliminary fourth quarter 2024 results will be released on Friday February 28, 2025, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontlineplc.cy ahead of the conference call. In order to attend the conference call you may do one of the following: a. WebcastGo to the Investor Relations section at www.frontlineplc.cy and follow the “Webcast” link, or access directly from the link below. Frontline plc Q4 2024 Webcast b. Conference CallParticipants will need to register online prior to the conference call via the link below. Dial-in details will be available when registered.             Frontline plc Q4 2024 Conference Call A Q&A session will be held after the teleconference/webcast....

Continue reading

Sandoz launches biosimilar Pyzchiva® (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesKey biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in biosimilars in US Strengthens US immunology portfolio and increases access to biologics for patients suffering from chronic inflammatory diseases, such as psoriasis and psoriatic arthritis Meeting a variety of patient needs, Pyzchiva® offers full suite of dosing options and extended stability compared with reference medicineBasel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the launch of Pyzchiva®* (ustekinumab-ttwe) in the US. From today, the medicine is commercially available to patients across the US. Developed by Samsung Bioepis Co., Ltd., and commercialized by Sandoz, Pyzchiva®...

Continue reading

Statement on Dan Bongino Being Named Deputy Director of the FBI

LONGBOAT KEY, Fla., Feb. 23, 2025 (GLOBE NEWSWIRE) — Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today released the following statement from CEO and Chairman Chris Pavlovski regarding the recent appointment of content creator Dan Bongino as Deputy Director of the FBI in the Trump Administration: “Dan Bongino is a pioneer and a free speech warrior, and it has been an honor to host his content on Rumble. More than just that, he has been a mentor to me personally through these important years of Rumble’s explosive growth, and he has become a dear friend I will have for life. Dan was one of the first major creators to move his content to Rumble in 2020 and has set many livestreaming records ever since. He believes strongly in the innate human right to self-expression—in fact, he’s turned it into an...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.